Tue, November 26, 2024

[ Tue, Nov 26th 2024 ]: Thomas Matters

Best Buy Stock Is Sinking After Earnings. Here's Why
Mon, November 25, 2024

[ Mon, Nov 25th 2024 ]: Thomas Matters

Top 10 mutual funds for doubling your wealth over time

[ Mon, Nov 25th 2024 ]: Thomas Matters

Stock Market Today: Dow, S&P 500 on track for rec .. mp picks Bessent to be Treasury secretary nominee

[ Mon, Nov 25th 2024 ]: Thomas Matters

What Are The 10 Best Crypto Coins To Invest In|Best Picks For 2024

[ Mon, Nov 25th 2024 ]: Thomas Matters

Why National Fuel Gas Is Still On My 'Buy' List

[ Mon, Nov 25th 2024 ]: Thomas Matters

Nvidia and Microsoft: Billionaire Ken Fisher Pours Money Into the Biggest AI Stocks

[ Mon, Nov 25th 2024 ]: Thomas Matters

'How can we maintain our lifestyle in retirement?'

[ Mon, Nov 25th 2024 ]: Thomas Matters

Best Low Spread Forex Brokers in the UK for November 2024

[ Mon, Nov 25th 2024 ]: Thomas Matters

Happy Belly's HEAL Wellness QSR Announces Signing .. chise and Real-Estate Location in Bolton, Ontario

[ Mon, Nov 25th 2024 ]: Thomas Matters

Isaac Newton and Momentum Investing

[ Mon, Nov 25th 2024 ]: Thomas Matters

How I Manage My Money: Firm owner, on £2.1k a month, prioritising her pension

[ Mon, Nov 25th 2024 ]: Thomas Matters

Is now a good time to invest in gold?

[ Mon, Nov 25th 2024 ]: Thomas Matters

What Scott Bessent's Treasury Secretary Nomination Means for Investors

[ Mon, Nov 25th 2024 ]: Thomas Matters

Investing with a clear conscience: How should Catholics manage their money?

[ Mon, Nov 25th 2024 ]: Thomas Matters

Bath & Body Works Stock Pops After Beat-And-Raise Quarter
Sun, November 24, 2024

[ Sun, Nov 24th 2024 ]: Thomas Matters

Here's Why Autocount Dotcom Berhad (KLSE:ADB) Has Caught The Eye Of Investors

[ Sun, Nov 24th 2024 ]: Thomas Matters

Hibiscus Petroleum Berhad First Quarter 2025 Earnings: EPS: RM0.095 (vs RM0.19 in 1Q 2024)

[ Sun, Nov 24th 2024 ]: Thomas Matters

Returns On Capital Signal Tricky Times Ahead For HealthEquity (NASDAQ:HQY)

[ Sun, Nov 24th 2024 ]: Thomas Matters

Those who invested in Yum! Brands (NYSE:YUM) five years ago are up 47%

[ Sun, Nov 24th 2024 ]: Thomas Matters

Quest Partners LLC Has $434,000 Stock Holdings in UGI Co. (NYSE:UGI)

[ Sun, Nov 24th 2024 ]: Thomas Matters

CytoDyn (OTCMKTS:CYDY) Holds 2024 Annual Meeting of Stockholders

[ Sun, Nov 24th 2024 ]: Thomas Matters

Insiders At Kinder Morgan Sold US$29m In Stock, Alluding To Potential Weakness

[ Sun, Nov 24th 2024 ]: Thomas Matters

Investing in BJ's Restaurants (NASDAQ:BJRI) a year ago would have delivered you a 15% gain
Wed, November 13, 2024

[ Wed, Nov 13th 2024 ]: George Steinberg

What are the best trades to look at going into the Holiday season?

[ Wed, Nov 13th 2024 ]: George Steinberg

New government directive might seriously impact TSMC chip deliveries

[ Wed, Nov 13th 2024 ]: George Steinberg

Predicting the direction of gold prices based after Trumps historic 2024 election win
Tue, November 12, 2024

[ Tue, Nov 12th 2024 ]: George Steinberg

**Vale S.A. (VALE)** is a Brazilian multinational .. oints highlighting the upside potential for Vale:

[ Tue, Nov 12th 2024 ]: George Steinberg

Intel Corporation (INTC) has several areas where it could see upside potential:
Tue, October 8, 2024

[ Tue, Oct 08th 2024 ]: WOPRAI

Brennan Hawken Maintained (BK) at Strong Buy with Increased Target to $82 on, Oct 8th, 2024

[ Tue, Oct 08th 2024 ]: WOPRAI

Ross Sandler Maintained (BKNG) at Buy on, Oct 8th, 2024

[ Tue, Oct 08th 2024 ]: WOPRAI

Ken Gawrelski Maintained (BKNG) at Hold on, Oct 8th, 2024

[ Tue, Oct 08th 2024 ]: WOPRAI

Terry Ma Maintained (BFH) at Sell with Decreased Target to $35 on, Oct 8th, 2024

[ Tue, Oct 08th 2024 ]: WOPRAI

Joshua Chan Maintained (BFAM) at Hold with Increased Target to $145 on, Oct 8th, 2024

[ Tue, Oct 08th 2024 ]: WOPRAI

Eric Schmidt Initiated (bcax) at Buy on, Oct 8th, 2024

[ Tue, Oct 08th 2024 ]: WOPRAI

Stephen Willey Initiated (bcax) at Strong Buy and Held Target at $47 on, Oct 8th, 2024

[ Tue, Oct 08th 2024 ]: WOPRAI

Judah Frommer Initiated (bcax) at Buy and Held Target at $35 on, Oct 8th, 2024

[ Tue, Oct 08th 2024 ]: WOPRAI

Tyler Van Buren Initiated (bcax) at Strong Buy on, Oct 8th, 2024

[ Tue, Oct 08th 2024 ]: WOPRAI

Robert Driscoll Reiterated (BDTX) at Buy and Held Target at $16 on, Oct 8th, 2024

[ Tue, Oct 08th 2024 ]: WOPRAI

Kevin Cassidy Maintained (btdr) at Strong Buy and Held Target at $9 on, Oct 8th, 2024

[ Tue, Oct 08th 2024 ]: WOPRAI

Tito Labarta Maintained (BAP) at Strong Sell with Increased Target to $160 on, Oct 8th, 2024

[ Tue, Oct 08th 2024 ]: WOPRAI

Michael Ciarmoli Maintained (B) at Hold with Increased Target to $48 on, Oct 8th, 2024
Mon, October 7, 2024

[ Mon, Oct 07th 2024 ]: WOPRAI

Robert Burns Maintained (BNTX) at Strong Buy with Increased Target to $150 on, Oct 7th, 2024

[ Mon, Oct 07th 2024 ]: WOPRAI

Deepak Mathivanan Reiterated (BKNG) at Hold on, Oct 7th, 2024

[ Mon, Oct 07th 2024 ]: WOPRAI

Vivek Juneja Maintained (BK) at Buy with Increased Target to $77 on, Oct 7th, 2024

[ Mon, Oct 07th 2024 ]: WOPRAI

Joanna Gajuk Downgraded (BKD) to Sell and Decreased Target to $6 on, Oct 7th, 2024

[ Mon, Oct 07th 2024 ]: WOPRAI

Benjamin Budish Maintained (BLK) at Buy on, Oct 7th, 2024

[ Mon, Oct 07th 2024 ]: WOPRAI

Mike Cyprys Maintained (BLK) at Buy on, Oct 7th, 2024

[ Mon, Oct 07th 2024 ]: WOPRAI

Brian Peterson Maintained (BLKB) at Buy with Decreased Target to $95 on, Oct 7th, 2024

CytoDyn (OTCMKTS:CYDY) Holds 2024 Annual Meeting of Stockholders

CytoDyn Inc. recently conducted its 2024 Annual Meeting of Stockholders on November 22, 2024. In a Form 8-K filing issued on the same day, the final voting results were disclosed, showing several key outcomes from the meeting.
The article from ETF Daily News discusses CytoDyn Inc.'s (OTC: CYDY) 2024 Annual Meeting of Stockholders, which took place on November 24, 2024. The meeting covered several key points including the company's progress on its lead drug candidate, leronlimab, for treating various diseases such as HIV, cancer, and autoimmune disorders. Shareholders voted on several proposals, including the election of directors, the ratification of the company's independent registered public accounting firm, and an advisory vote on executive compensation. CEO Dr. Nader Pourhassan provided updates on clinical trials, regulatory milestones, and strategic partnerships aimed at advancing leronlimab through the FDA approval process. The meeting also highlighted the company's financial health, ongoing research, and future plans to expand its therapeutic pipeline.

Read the Full ETF Daily News Article at [ https://www.etfdailynews.com/2024/11/24/cytodyn-otcmktscydy-holds-2024-annual-meeting-of-stockholders/ ]